Mariam K. Hassan, Ph.D.
Affiliations: | 2005 | West Virginia University, Morgantown, WV, United States |
Area:
Health Care ManagementGoogle:
"Mariam Hassan"Parents
Sign in to add mentor| Suresh Madhavan | grad student | 2005 | West Virginia University | |
| (Evaluating medication utilization patterns and healthcare outcomes in patients receiving antipsychotics.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mannix S, Hassan M, Tummala R, et al. (2015) Content validity of the Sheehan Irritability Scale in patients with major depressive disorder. International Clinical Psychopharmacology |
| Khan SA, Revicki DA, Hassan M, et al. (2015) Assessing the reliability and validity of the Sheehan Irritability Scale in patients with major depressive disorder. The Journal of Clinical Psychiatry |
| Awad G, Hassan M, Loebel A, et al. (2014) Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia. Bmc Psychiatry. 14: 53 |
| Rajagopalan K, Hassan M, Awad AG, et al. (2014) Poster #S145 HEALTH-RELATED QUALITY OF LIFE OUTCOMES AMONG PATIENTS WITH SCHIZOPHRENIA: RESULTS FROM A LONG-TERM NATURALISTIC TRIAL OF PATIENTS SWITCHING TO LURASIDONE FROM OTHER ANTIPSYCHOTICS Schizophrenia Research. 153 |
| O’Day K, Hassan M, Rajagopalan K, et al. (2014) Cost-effectiveness analysis of lurasidone versus quetiapine XR in patients with bipolar depression Value in Health. 17 |
| Hassan M, Dansie E, Rajagopalan K, et al. (2014) The effect of lurasidone on functional remission among patients with bipolar depression Value in Health. 17 |
| Rajagopalan K, Hassan M, O'Day K, et al. (2013) Cost-effectiveness of lurasidone vs aripiprazole among patients with schizophrenia who have previously failed on an atypical antipsychotic: an indirect comparison of outcomes from clinical trial data. Journal of Medical Economics. 16: 951-61 |
| Awad G, Hassan M, Loebel A, et al. (2013) 1057 – Evaluation of quality of life, psychosocial functioning, and medication adherence among patients switched to lurasidone from other antipsychotics European Psychiatry. 28: 1 |
| Hassan M, Wade SW, Meyer NM, et al. (2013) Hospitalizations among bipolar disorder patients before and after initiating lurasidone in a commercially insured population Value in Health. 16 |
| Awad G, Hassan M, Loebel A, et al. (2013) Evaluation of health related quality of life outcomes among patients with schizophrenia switched to lurasidone from other antipsychotics Value in Health. 16 |